Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2021 | 10-2020 | 07-2020 | 04-2020 | 01-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,977 | N/A | -20,009 | -14,180 | -7,857 |
| Depreciation Amortization | 454 | N/A | 1,499 | 1,003 | 501 |
| Other Working Capital | 462 | N/A | -1,829 | -1,322 | -863 |
| Other Operating Activity | 275 | 0 | 1,617 | 1,079 | 511 |
| Operating Cash Flow | $-2,786 | $N/A | $-18,722 | $-13,420 | $-7,708 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -210 | N/A | -421 | -358 | -238 |
| Other Investing Activity | -210 | 0 | -421 | -358 | -238 |
| Investing Cash Flow | $-210 | $N/A | $-421 | $-358 | $-238 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,136 | N/A | 10,626 | 9,632 | 9,739 |
| Financing Cash Flow | $11,136 | $N/A | $10,626 | $9,632 | $9,739 |
| Beginning Cash Position | 25,178 | N/A | 32,363 | 32,363 | 32,363 |
| End Cash Position | 33,318 | N/A | 23,846 | 28,217 | 34,156 |
| Net Cash Flow | $8,140 | $N/A | $-8,517 | $-4,146 | $1,793 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,786 | N/A | -18,722 | -13,420 | -7,708 |
| Free Cash Flow | -2,786 | 0 | -18,722 | -13,420 | -7,708 |